Tag: XAI
-

Fujitsu introduces ‘explainable AI’ for use in genomic medicine and cancer treatment planning
Fujitsu Limited has made groundbreaking strides in integrating explainable AI technology into genomic medicine and cancer treatment planning. Our new multimodal AI technologies, launched on May 9, 2024, in Kawasaki, enable the creation of knowledge graphs from diverse data formats—text, images, and numerical data—which simplify the interpretation of complex datasets. Our technology has been rigorously tested on…